Novartis delivered solid sales and profit growth in the first quarter of 2014
- Details
- Category: Novartis

Bristol-Myers Squibb ranks first on 2014 Best Corporate Citizens List
- Details
- Category: Bristol-Myers Squibb

Novartis announces portfolio transformation
- Details
- Category: Novartis

Abbott reports first-quarter 2014 results
- Details
- Category: Abbott

Roche with good start in 2014
- Details
- Category: Roche

Abbott completes enrollment of Absorb™ randomized clinical trials in the United States, Japan and China
- Details
- Category: Abbott

Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia
- Details
- Category: Novartis

More Pharma News ...
- Merck Serono enters into research agreement with Pfizer and Broad Institute
- Bayer HealthCare to significantly increase production capacity in China
- AstraZeneca and MRC enter strategic collaboration
- Novo Nordisk launches 'Cities Changing Diabetes' to fight urban diabetes
- Where do you start when developing a new medicine?
- Novartis announces US FDA approval of Xolair® for chronic idiopathic urticaria
- Bayer to invest more than 500 million Euros for the manufacturing of hemophilia A products currently in development